OpenAlex
PricingAboutJobs
Log inGet started
Work

Bortezomib Versus Non-Bortezomib Based Initial Treatment for Transplant Ineligible Patients with Light Chain Amyloidosis

HTML

Year: 2017
Type: article
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/j.clml.2017.03.254
Authors: Surbhi Sidana, Nidhi Tandon, Angela Dispenzieri, Morie A. Gertz, Francis Buadi, Martha Lacy, David Dingli, Amie Fonder, Suzanne Hayman, Miriam Hobbs, Wilson Gonsalves, Yi Lisa Hwa, Prashant Kapoor, Robert Kyle, Nelson Leung, Ronald Go, John Lust, Stephen Russell, Steven Zeldenrust, S.Vincent Rajkumar, Shaji Kumar
Institution: Mayo Clinic
Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2607080860
FWCI: 0.097
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms